HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline Summary From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology.

Sorry, there's nothing here.

Cite this paper

@article{Bartley2017HER2TA, title={HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline Summary From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology.}, author={Angela Nicole Bartley and M. Kay Washington and Nofisat Ismaila and Jaffer A. Ajani}, journal={Journal of oncology practice}, year={2017}, volume={13 1}, pages={53-57} }